AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionBelpointe Asset Management LLC
Latest Disclosed Ownership43,375 shares
Latest Disclosed Value $ 9,433,769
Belpointe Asset Management LLC reports 22.06% increase in ownership of 4AB / AbbVie Inc.

On April 28, 2026 - Belpointe Asset Management LLC filed a 13F-HR form disclosing ownership of 43,375 shares of AbbVie Inc. (BG:4AB) valued at $9,433,769 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 35,535 shares of AbbVie Inc.. This represents a change in shares of 22.06% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F ABBVIE COM 00287Y109 43,375 7,840 22.06 9,434 16.18 0.3444
2026-01-27 2025-12-31 13F ABBVIE COM 00287Y109 35,535 -113 -0.32 8,119 -1.64 0.2933
2025-11-03 2025-09-30 13F ABBVIE COM 00287Y109 35,648 2,618 7.93 8,254 34.63 0.3153
2025-07-22 2025-06-30 13F ABBVIE COM 00287Y109 33,030 -1,595 -4.61 6,131 -15.48 0.2554
2025-05-20 2025-03-31 13F ABBVIE COM 00287Y109 34,625 -4,903 -12.40 7,255 -6.51 0.3775
2025-02-13 2024-12-31 13F ABBVIE COM 00287Y109 39,528 -242 -0.61 7,760 -1.20 0.4674
2024-11-13 2024-09-30 13F ABBV COM 00287Y109 39,770 2,062 5.47 7,854 21.43 0.4711
2024-08-02 2024-06-30 13F ABBVIE COM 00287Y109 37,708 1,010 2.75 6,468 -3.22 0.4511
2024-05-08 2024-03-31 13F ABBVIE COM 00287Y109 36,698 2,148 6.22 6,683 24.80 0.5005
2024-02-13 2023-12-31 13F ABBVIE COM 00287Y109 34,550 403 1.18 5,354 5.19 0.4703
2023-11-15 2023-09-30 13F ABBVIE COM 00287Y109 34,147 971 2.93 5,090 13.90 0.5271
2023-08-15 2023-06-30 13F ABBVIE COM 00287Y109 33,176 -25,476 -43.44 4,470 -52.19 0.4728
2023-05-15 2023-03-31 13F ABBVIE COM 00287Y109 58,652 -2,366 -3.88 9,347 -5.21 0.5048
2023-02-08 2022-12-31 13F ABBVIE COM 00287Y109 61,018 4,807 8.55 9,861 30.71 0.5958
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 56,211 10,423 22.76 7,544 7.56 0.5099
2022-08-02 2022-06-30 13F ABBVIE COM 00287Y109 45,788 -9,900 -17.78 7,014 -22.31 0.4702
2022-04-28 2022-03-31 13F ABBVIE COM 00287Y109 55,688 -11,610 -17.25 9,028 -0.92 0.5471
2022-02-15 2021-12-31 13F ABBVIE COM 00287Y109 67,298 1,474 2.24 9,112 28.34 0.5680
2021-11-15 2021-09-30 13F ABBVIE COM 00287Y109 65,824 12,164 22.67 7,100 17.47 0.4841
2021-08-09 2021-06-30 13F ABBVIE COM 00287Y109 53,660 2,642 5.18 6,044 9.47 0.4350
2021-05-14 2021-03-31 13F ABBVIE COM 00287Y109 51,018 -6,547 -11.37 5,521 -10.48 0.4726
2021-02-16 2020-12-31 13F ABBVIE COM 00287Y109 57,565 3,145 5.78 6,167 29.37 0.5535
2020-11-13 2020-09-30 13F/A-1 ABBVIE COM 00287Y109 54,420 -8,829 -13.96 4,767 -23.24 0.5305
2020-11-13 2020-09-30 13F ABBVIE COM 00287Y109 31,487 2,398
2020-07-20 2020-06-30 13F ABBVIE COM 00287Y109 63,249 31,762 100.87 6,210 158.97 0.8040
2020-07-20 2020-03-31 13F ABBVIE COM 00287Y109 31,487 -1,848 -5.54 2,398 -18.77 0.4200
2020-02-18 2019-12-31 13F ABBVIE COM 00287Y109 33,335 5,991 21.91 2,952 42.54 0.3746
2020-01-16 2019-09-30 13F ABBVIE COM 00287Y109 27,344 3,589 15.11 2,071 19.92 0.3350
2019-11-22 2019-06-30 13F ABBVIE COM 00287Y109 23,755 -597 -2.45 1,727 -11.98 0.3397
2019-06-11 2019-03-31 13F ABBVIE COM 00287Y109 24,352 103 0.42 1,962 -12.25 0.3832
2019-03-06 2018-12-31 13F ABBVIE COM 00287Y109 24,249 4,342 21.81 2,236 18.75 0.5667
2018-11-23 2018-09-30 13F ABBVIE COM 00287Y109 19,907 -943 -4.52 1,883 -2.54 0.2978
2018-08-06 2018-06-30 13F ABBVIE COM 00287Y109 20,850 -1,248 -5.65 1,932 -7.65 0.5398
2018-08-06 2018-03-31 13F ABBVIE COM 00287Y109 22,098 -7,702 -25.85 2,092 -27.41 0.6098
2018-02-14 2017-12-31 13F ABBVIE COM 00287Y109 29,800 5,503 22.65 2,882 33.49 0.6313
2017-11-16 2017-09-30 13F ABBVIE COM 00287Y109 24,297 24,297 2,159 0.5051
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.